Evidence map›Paper›PMID 29510343›Full record

ArticleNeoplasia (New York, N.Y.)2018

S-phase Specific Downregulation of Human O

Agm Mostofa, Surendra R Punganuru, Hanumantha Rao Madala, Kalkunte S Srivenugopal

Open access · goldAbstract read
In one paragraph

Article in Neoplasia (New York, N.Y.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Genetic and epigenetic landscape of OExploration of targeted anti-tumor therapy · 2025
    Review
  3. CDKN1A/p21 in Breast Cancer: Part of the Problem, or Part of the Solution?International journal of molecular sciences · 2023
    Review
  4. Review
  5. Revisiting the Function of p21International journal of molecular sciences · 2022
    Review
  6. Resolving the subtle details of human DNA alkyltransferase lesion search and repair mechanism by single-molecule studies.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  7. Article
  8. Article
  9. The complexity and regulation of repair of alkylation damage to nucleic acids.Critical reviews in biochemistry and molecular biology · 2021
    Review
  10. Article
  11. Review
  12. Downregulation of MGMT promotes proliferation of intrahepatic cholangiocarcinoma by regulating p21.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2020
    Article
  13. Article
  14. Article
  15. Article
  16. Impact of rs12917 MGMT Polymorphism on [Molecular imaging and biology · 2019
    Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Agm MostofaDepartment of Biomedical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, 1406 S. Coulter Drive, Amarillo, TX 79106, USA.
Surendra R PunganuruDepartment of Biomedical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, 1406 S. Coulter Drive, Amarillo, TX 79106, USA.
Hanumantha Rao MadalaDepartment of Biomedical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, 1406 S. Coulter Drive, Amarillo, TX 79106, USA.
Kalkunte S SrivenugopalDepartment of Biomedical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, 1406 S. Coulter Drive, Amarillo, TX 79106, USA. Electronic address: Kalkunte.Srivenugopal@ttuhsc.edu.
Texas Tech University · USTexas Tech University Health Sciences Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Whether the antimutagenic DNA repair protein MGMT works solo in human cells and if it has other cellular functions is not known. Here, we show that human MGMT associates with PCNA and in turn, with the cell cycle inhibitor, p21

Indexed as

Cell Cycle ProteinsCell Line, TumorCyclin-Dependent Kinase Inhibitor p21DNA DamageDNA Modification MethylasesDNA Repair EnzymesDown-RegulationG1 PhaseGliomaHCT116 CellsHT29 CellsHumansS PhaseTumor Suppressor ProteinsUbiquitinUbiquitin-Protein LigasesCDKN1A protein, humanCell Cycle ProteinsCyclin-Dependent Kinase Inhibitor p21DNA Modification MethylasesDNA Repair EnzymesMGMT protein, humanTumor Suppressor ProteinsUbiquitinUbiquitin-Protein Ligases

Identifiers

PMID29510343
PMCPMC5909491
OpenAlexW2794330762

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.